Navigation Links
Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV
Date:12/1/2009

Recent Reviews In Major Peer Review Journals Have Identified The PADDS As One Of The Most Promising New Developments For The Evidence-Based Assessment Of Attention And Executive Functioning Difficulties. Some Of The Most Recent Are Listed Below.

(PRWEB) December 1, 2009 -- Review written by: Leesa V. Huang Ph.D. for the Journal of Attention Disorders, Volume 13, No. 3 November 2009. A nice synopsis of this article is available on PubMed Here

Review written by: Steven Spector, Ph.D., Eric A. Youngstrom, Ph.D., Kristin D. Anderson, Psy.D. for The ADHD Report Volume 17 Number 5, October 2009

An Expert Interview with Dr. Thomas Pedigo on Evidence-Based Assessment by Laurie Barclay, MD for MedScape Today from WebMD

An in depth review from Buros Institute of Mental Measurments is scheduled to be released electronically in Test Reviews Online January of 2010 and will be included in theBuros' 18th Mental Measurments Yearbook in Spring 2010.

The Pediatric Attention Disorders Diagnostic Screener, or PADDS, is a powerful new evidence-based Attention Deficit Hyperactivity Disorder (ADHD) assessment software program used for testing attention and executive function disorders in children ages 6 through 12. Consisting of the Computer Administered Diagnostic Interview (CADI), the Swanson, Nolan, and Pelham—IV (SNAP-IV) Parent rating scale and Teacher rating scale, and three computer administered objective measures called the Target Tests of Executive Functioning (TTEF). The actuarial / statistical reporting functions make available an automatically calculated predictive index for scoring and reporting. This method uses Bayesian probability to calculate diagnostic likelihood ratios, which are then graphed on a Nomogram to provide incremental validity when combining results from multiple measures so that each unique data source can be allowed to contribute to (or detract from, as the case may be) the prediction (Cumulative probability) of the diagnosis. The results are also given in a more traditional, normalized, relative Standard score, T-score, Z-Score, and Percentile rank format for comparison to the non-clinical reference group.

We are currently engaging in a nationwide normative effort for our newly developed set of measures of Executive Functioning TTEF-OV. These measures referred to as the Target Tests of Executive Functioning-OV (Older Version) represent the upward extension of the child version of these measures published by TTI. These measures are designed to help gain greater insight for an overall assessment of attention and working memory in Adolescents and Adults. TTI expects to have this research completed and published in the spring of 2010, as well as a completed, release version of the TTEF-OV software, with new Auditory Measures for both versions expected soon after.

PADDS and TTEF-OV are designed for use by Pediatricians, Psychiatrists, Psychologists, and other qualified mental health professionals. They are available directly from Targeted Testing Inc and other major psychological test publishers.

Targeted Testing Inc., founded by Dr. Thomas K. Pedigo Ed.D. and Kenneth L. Pedigo, is currently developing and researching several new lines of computer administered and evidence-based assessments systems to be used in screening psychological disorders. Their primary developmental approach consists of two main areas of focus. The first relates to integrating an updated construct of the disorders and the specific criteria, while the second addresses the question of how to enhance diagnostic accuracy in an efficient manner.

Targeted Testing Inc. is a member of the Association of Test Publishers.

For more information about the PADDS or TTEF-OV, please contact Kenneth Pedigo by calling 1-877-425-1093, or visit our website www.targettest.com

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3270314.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Study suggests brain tumors need treatment with multiple targeted drugs
2. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
3. Research suggests targeted treatment strategies for lupus
4. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
6. Gleevec, the targeted cancer pill, delivers more good news to patients
7. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
8. Light powered platinum more targeted and 80 times more powerful than similar cancer treatments
9. A major step toward a more targeted treatment for auto-immune diseases?
10. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
11. New study of targeted therapies for breast cancer -- model for global clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Targeted Testing Receives Favorable Reviews On  PADDS,  Begins  Nationwide Research Study On The Target Tests of Executive Functioning-OV
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and ... the issue of world hunger, and shares the simple and achievable answer. “The Land ... and member of the Fairview Missionary Church in Angola, Indiana where he works with ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the ... Congressional political games that circumvent health needs of over 30 million. Many interviews with ... anxieties and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... innovators, engineers, and scientists from around the world, announces the launch of its ... quick and easy portal to research breakthroughs and trending news, vital information on ...
(Date:1/19/2017)... Park City, Utah (PRWEB) , ... January 19, ... ... Sundance Film Festival in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew ... Lounge to provide a condensed version of the clinic’s leading recovery program. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
(Date:1/19/2017)... January 19, 2017 Pfizer ... the Milner Therapeutics Consortium   Major ... Cambridge   The Milner ... PFE ) as a partner to the Milner Therapeutics ... enables the efficient transfer of materials between industry and ...
Breaking Medicine Technology: